PeptideDB

Aloe-emodin-8-O-β-D-glucopyranoside 33037-46-6

Aloe-emodin-8-O-β-D-glucopyranoside 33037-46-6

CAS No.: 33037-46-6

Aloe-emodin-8-O-β-D-glucopyranoside is a compound extracted from Saussrurea lappa and is a mild inhibitor of human prot
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Aloe-emodin-8-O-β-D-glucopyranoside is a compound extracted from Saussrurea lappa and is a mild inhibitor of human protein tyrosine phosphatase 1B (hPTP1B) with IC50 of 26.6 μM.

Physicochemical Properties


Molecular Formula C21H20O10
Molecular Weight 432.3775
Exact Mass 432.105
CAS # 33037-46-6
PubChem CID 5317644
Appearance Light yellow to yellow solid powder
Density 1.673±0.06 g/cm3
Boiling Point 829.9±65.0 °C at 760 mmHg
Melting Point 236-237 ºC
Flash Point 295.2±27.8 °C
Vapour Pressure 0.0±3.2 mmHg at 25°C
Index of Refraction 1.726
LogP -0.1
Hydrogen Bond Donor Count 6
Hydrogen Bond Acceptor Count 10
Rotatable Bond Count 4
Heavy Atom Count 31
Complexity 685
Defined Atom Stereocenter Count 5
SMILES

C1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C2=O)C=C(C=C4O)CO

InChi Key KIZBWUUJNJEYCM-JNHRPPPUSA-N
InChi Code

InChI=1S/C21H20O10/c22-6-8-4-10-14(11(24)5-8)18(27)15-9(16(10)25)2-1-3-12(15)30-21-20(29)19(28)17(26)13(7-23)31-21/h1-5,13,17,19-24,26,28-29H,6-7H2/t13-,17-,19+,20-,21-/m1/s1
Chemical Name

1-hydroxy-3-(hydroxymethyl)-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Aloe-emodin-8-O-β-D-glucopyranoside targets protein tyrosine phosphatase 1B (PTP1B) (IC₅₀ = 38.5 μM) [1]
ln Vitro - Aloe-emodin-8-O-β-D-glucopyranoside exhibited dose-dependent inhibitory activity against recombinant human PTP1B enzyme, with an IC₅₀ value of 38.5 μM [1]
- The compound showed no significant inhibitory effect on other phosphatases (e.g., TCPTP) at concentrations up to 100 μM, indicating moderate selectivity for PTP1B [1]
Enzyme Assay - Recombinant human PTP1B enzyme was used for the inhibition assay, with p-nitrophenyl phosphate (pNPP) as the synthetic substrate [1]
- The reaction was conducted in a buffer system at 37°C, with serial dilutions of Aloe-emodin-8-O-β-D-glucopyranoside (0.1-100 μM) added to the mixture of enzyme and substrate [1]
- After incubation for a specific period, the reaction was terminated by adding a stop solution, and the absorbance of the product (p-nitrophenol) was measured spectrophotometrically at 405 nm [1]
- The inhibitory rate of PTP1B activity was calculated by comparing the absorbance of the treatment group with the blank control group, and the IC₅₀ value was determined via nonlinear regression analysis of the dose-response curve [1]
References

[1]. PTP1B inhibitors from Saussrurea lappa. J Asian Nat Prod Res. 2006 Apr-May;8(3):281-6.

Additional Infomation Aloe-emodin-8-O-beta-D-glucopyranoside has been reported in Rheum palmatum, Senna alexandrina, and Rheum officinale with data available.
- Aloe-emodin-8-O-β-D-glucopyranoside is a natural compound isolated from the plant Saussrurea lappa (commonly known as Aucklandia lappa or costus root) [1]
- As a PTP1B inhibitor, the compound has potential therapeutic implications for metabolic diseases (e.g., type 2 diabetes mellitus) and cancer, since PTP1B is involved in regulating insulin signaling and oncogenic pathways [1]
- The compound is a glycosylated derivative of aloe-emodin, with the glucopyranoside moiety potentially influencing its solubility and biological activity compared to the aglycone form [1]

Solubility Data


Solubility (In Vitro) DMSO : ~50 mg/mL (~115.64 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (5.78 mM) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3128 mL 11.5639 mL 23.1278 mL
5 mM 0.4626 mL 2.3128 mL 4.6256 mL
10 mM 0.2313 mL 1.1564 mL 2.3128 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.